20-Feb-2026
No headlines found.
No press releases found.
No news found.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
Bioceres Crop Solutions Corp. - trades on the NASDAQ stock market under the symbol BIOX.
As of February 20, 2026, BIOX stock price declined to $0.59 with 143,272 million shares trading.
BIOX has a beta of 0.93, meaning it tends to be less sensitive to market movements. BIOX has a correlation of 0.03 to the broad based SPY ETF.
BIOX has a market cap of $35.91 million. This is considered a Sub-Micro Cap stock.
Last quarter Bioceres Crop Solutions Corp. - reported $77 million in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-15 million and missed earnings estimates by -$.05.
In the last 3 years, BIOX traded as high as $14.20 and as low as $.53.
The top ETF exchange traded funds that BIOX belongs to (by Net Assets): ARGT, QQQS, KROP.
BIOX has underperformed the market in the last year with a return of -87.5%, while the SPY ETF gained +14.1%. In the last 3 month period, BIOX fell short of the market, returning -58.5%, while SPY returned +6.0%. However, in the most recent 2 weeks BIOX has outperformed the stock market by returning +5.1%, while SPY returned -0.2%.
BIOX support price is $.56 and resistance is $.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIOX shares will trade within this expected range on the day.
